Oncology Institute (TOIIW) Invested Capital (2019 - 2026)

Oncology Institute (TOIIW) has 8 years of Invested Capital data on file, last reported at $62.3 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 21.07% year-over-year to $62.3 million; the trailing twelve-month figure through Mar 2026 stood at $62.3 million (down 21.07% YoY), and the FY2025 full-year result was $61.7 million, down 36.23% from the prior year.
• Invested Capital for Q1 2026 stood at $62.3 million, up from $61.7 million in the prior quarter.
• Across five years, Invested Capital topped out at $207.0 million in Q3 2022 and bottomed at $61.7 million in Q4 2025.
• The 5-year median for Invested Capital is $124.0 million (2022), against an average of $123.7 million.
• The widest annual swing landed in 2022, when Invested Capital surged 335.49%; it then sank 44.58% in 2025.
• A 5-year view of Invested Capital shows it stood at $203.8 million in 2022, then decreased by 29.41% to $143.9 million in 2023, then plunged by 32.76% to $96.7 million in 2024, then slumped by 36.23% to $61.7 million in 2025, then rose by 1.05% to $62.3 million in 2026.
• The last three Invested Capital figures came in at $62.3 million (Q1 2026), $61.7 million (Q4 2025), and $63.9 million (Q3 2025), per Business Quant data.

Peer Comparison